CRISPR Therapeutics (CRSP) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today -8

4 insiders sold $3.6M. No buys.

SellSamarth Kulkarni$2.4MChief Executive Officerat $49.78 on Oct 19, filed Oct 20

SellSamarth KulkarniChief Executive Officer$2.4Mat $49.78 on Oct 19, filed Oct 20

SellSamarth Kulkarni$202KChief Executive Officerat $49.26 on Oct 14, filed Oct 15

SellSamarth KulkarniChief Executive Officer$202Kat $49.26 on Oct 14, filed Oct 15

SellJames R. Kasinger$51KGeneral Counsel and Secretaryat $49.26 on Oct 14, filed Oct 15

SellJames R. KasingerGeneral Counsel and Secretary$51Kat $49.26 on Oct 14, filed Oct 15

From SEC Form 4s, the newest filed Oct 20, 2026 · Insiders have 2 business days to file a trade

2 more filings on CRSP in the last 6 months, for Pro members. See them free →

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 5 tradesSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on CRSP with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at CRISPR Therapeutics

Insider trades by person

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about CRSP's insider trades

As of Nov 2, 2026: CRISPR Therapeutics (CRSP) has 5 insider filings on record in the last 6 months, the newest filed Oct 20, 2026. Its Quality Score is -8 (Poor). Scores as of 8:00 PM ET, 15 minutes behind.

Are CRSP insiders buying or selling?

4 insiders sold $3.6M across 5 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Samarth Kulkarni, Chief Executive Officer, sold $2.4M on Oct 19, 2026.

Who are CRSP's biggest insider sellers?

By the dollars of their sales in the last 6 months: Samarth Kulkarni (Chief Executive Officer), 2 sales; Ali Behbahani (Director), 1 sale; Naimish Patel (Chief Medical Officer), 1 sale. 4 insiders sold in all.

When did a CRSP insider last buy?

No CRSP insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Samarth Kulkarni on Oct 19, 2026.

CRISPR Therapeutics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.